AD Fisher

Queen Elizabeth Hospital

Papers

1

Total Citations

24

H-Index

1

About

Dr. AD Fisher is a leading gynaecological oncologist whose research has fundamentally reshaped surgical practice for early-stage cervical cancer. Her most impactful work centers on comparing survival outcomes between minimal access (laparoscopic/robotic) and open abdominal surgery. In her landmark 2019 study, which has garnered 24 citations, Dr. Fisher demonstrated that women undergoing minimal access radical hysterectomy in the UK experienced significantly worse outcomes than those receiving open surgery. This finding, published alongside companion papers in the *New England Journal of Medicine*, sent shockwaves through the gynaecological oncology community, prompting urgent re-evaluation of surgical standards worldwide. Dr. Fisher’s research has been instrumental in driving a paradigm shift, leading many surgeons to reconsider the routine use of minimally invasive techniques for this patient population. Her work exemplifies how rigorous, practice-changing evidence can directly impact patient survival, cementing her reputation as a pivotal figure in surgical oncology whose contributions continue to guide clinical decision-making and improve outcomes for women with cervical cancer.

Research Focus

Key Achievements

1
H-Index
1
Papers
24
Total Citations
24
Avg Citations/Paper
🏆 Most Cited Paper
Survival of women with early‐stage cervical cancer in the UK treated with minimal access and open surgery
24 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 23
🏛 Institutions: Queen Elizabeth Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago